project id: TCGA-CESC; case submitter id: TCGA-ZX-AA5X; source center: 23; state: released; a260 a280 ratio: 1.83; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.52; rna integrity number: 7.2; age at index: 64; days to birth: -23440; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1949; age at diagnosis: 23440; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic t: TX; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 119.0; figo stage: Stage IIIB; icd 10 code: C53.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: not reported; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 46; days to sample procurement: 0; initial weight: 70.0; portion submitter id: TCGA-ZX-AA5X-01A-11; percent lymphocyte infiltration: 10.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 10.0; percent stromal cells: 30.0; percent tumor cells: 60.0; percent tumor nuclei: 60.0;